Cedars-Sinai Outpatient Cancer Center is a clinical research site located in Los Angeles, California, United States 90048.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
Cedars-Sinai Outpatient Cancer Center has participated in 8 clinical trials.
Therapeutic areas: Non Functioning Entero-pancreatic Endocrine Tumour, Rhabdomyosarcoma, Malignant Peripheral Nerve Sheath Tumors.
Sponsors: Ipsen, Sarcoma Alliance for Research through Collaboration, ImmunoGen, Inc..
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Cedars-Sinai Outpatient Cancer Center has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Cedars-Sinai Outpatient Cancer Center has 8 clinical trials on record. Their work covers Non Functioning Entero-pancreatic Endocrine Tumour, Rhabdomyosarcoma, Malignant Peripheral Nerve Sheath Tumors.
Yes — Cedars-Sinai Outpatient Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.